Alterity Therapeutics (ATHE) Revenue Growth (1y) (2010 - 2025)
Alterity Therapeutics (ATHE) Revenue Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 37.90% |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 64.24% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 7.82% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | 19.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.90% |
| Dec 31, 2024 | -8.70% |
| Jun 30, 2024 | 131,333,910.67% |
| Dec 31, 2023 | -18.82% |
| Dec 31, 2022 | 3.56% |
| Dec 31, 2021 | -99.32% |
| Dec 31, 2020 | 41,013.10% |
| Dec 31, 2019 | -65.90% |
| Dec 31, 2018 | 474.49% |
| Dec 31, 2017 | -68.63% |
| Jun 30, 2011 | 57.40% |
| Jun 30, 2010 | -94.10% |